Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields.

Type
Public
HQ
New Brunswick, US
Founded
1886
Size (employees)
134,000 (est)+7%
Website
jnj.com
Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US
Report incorrect company information

Key People/Management at Johnson & Johnson

Alex Gorsky

Alex Gorsky

Chairman, Board of Directors and Chief Executive Officer
Dominic J. Caruso

Dominic J. Caruso

Executive Vice President, Chief Financial Officer
Joaquin Duato

Joaquin Duato

Executive Vice President and Worldwide Chairman, Pharmaceuticals
Ashley McEvoy

Ashley McEvoy

Company Group Chairman, Consumer Medical Devices
Jorge Mesquita

Jorge Mesquita

Executive Vice President, Worldwide Chairman, Consumer
Sandra E. Peterson

Sandra E. Peterson

Group Worldwide Chair
Show more

Johnson & Johnson Office Locations

Johnson & Johnson has offices in Neenah, Solothurn, Zug, Dhaka and in 24 other locations
New Brunswick, US (HQ)
One Johnson & Johnson Plaza
Greenville, US
204 Greenville Blvd SW
Solothurn, CH
21 Luzernstrasse
Zug, CH
Gubelstrasse 34, 6300
Show all (28)
Report incorrect company information

Johnson & Johnson Financials and Metrics

Johnson & Johnson Revenue

Embed Graph
Johnson & Johnson's revenue was reported to be $71.89 b in FY, 2017 which is a 2.6% increase from the previous period.
USD

Net income (Q1, 2019)

4.4 b

Market capitalization (18-Jul-2018)

342.8 b

Closing share price (18-Jul-2018)

127.8

Cash (1-Apr-2018)

14.6 b

EV

358 b
Johnson & Johnson's current market capitalization is $342.8 b.
Annual
USDFY, 2013FY, 2014FY, 2016FY, 2017

Revenue

71.3 b74.3 b70.1 b71.9 b

Revenue growth, %

4%(6%)3%

Cost of goods sold

22.3 b22.7 b21.5 b21.7 b

Gross profit

49 b51.6 b48.5 b50.2 b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

17.4 b17.8 b17.1 b17.5 b18.5 b17.8 b17.8 b18.8 b19.7 b

Cost of goods sold

5.3 b5.4 b5.2 b5.3 b5.3 b5.5 b5.4 b5.8 b6.9 b6.6 b

Gross profit

12.1 b12.4 b11.9 b12.2 b13.1 b12.3 b12.4 b13 b12.7 b

Gross profit Margin, %

70%70%69%70%71%69%70%69%65%
Annual
USDFY, 2013FY, 2014FY, 2016FY, 2017

Cash

20.9 b14.5 b13.7 b19 b

Accounts Receivable

11.7 b11 b10.7 b11.7 b

Prepaid Expenses

4 b3.5 b3 b3.3 b

Inventories

7.9 b8.2 b8.1 b8.1 b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

12 b10.6 b13.6 b13.9 b18.6 b18.2 b20.9 b12.6 b15.7 b14.6 b

Accounts Receivable

11.5 b12 b11.4 b11.4 b12.1 b11.8 b12.3 b13.3 b13.2 b

Prepaid Expenses

3.7 b3.1 b3 b3.3 b3.1 b2.6 b2.8 b3 b2.9 b

Inventories

8.1 b8.3 b8.2 b8.2 b8.5 b8.5 b8.9 b9.7 b9.5 b9 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

13.8 b16.3 b15.4 b16.5 b

Depreciation and Amortization

4.1 b3.9 b3.7 b3.8 b

Inventories

(622 m)(1.1 b)(449 m)(249 m)

Accounts Payable

1.8 b955 m(3 m)656 m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

4.3 b8.8 b12.2 b4.3 b8.5 b12.7 b4.4 b8.2 b12 b4.4 b

Depreciation and Amortization

895 m1.8 b2.7 b891 m1.8 b2.7 b912 m2.1 b3.8 b

Inventories

(276 m)(537 m)(719 m)(190 m)(443 m)(408 m)(368 m)(421 m)(193 m)(322 m)

Accounts Payable

(2.5 b)(2.2 b)1.6 b(2.3 b)(1 b)(1.2 b)(2 b)(1.2 b)339 m
USDY, 2018

EV/CFO

99.3 x

Financial Leverage

2.5 x
Show all financial metrics

Johnson & Johnson Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017

Manufacturing Facilities

134 121 119 125

Facilities

265 250 230 260

Countries

60 60 60 60

Discovery Projects

100 150
Show all operating metrics

Johnson & Johnson Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Actelion Pharmaceuticals (2 k)January 26, 2017$30 b
Abott Medical Optics September 16, 2016$4.33 b
Vogue International June 02, 2016$3.30 b
Novira Therapeutics November 08, 2015
XO1 March 20, 2015
Alios BioPharma September 30, 2014$1.75 b
Aragon Pharmaceuticals June 17, 2013$1 b
Acclarent
Advanced Sterilization Products Services Inc.
ALZA Corporation
Show more

Johnson & Johnson Revenue Breakdown

Embed Graph

Johnson & Johnson revenue breakdown by business segment: 18.5% from Consumer, 46.5% from Pharmaceutical and 34.9% from Medical Devices

Report incorrect company information

Johnson & Johnson Online and Social Media Presence

Embed Graph
Report incorrect company information

Johnson & Johnson Company Life and Culture

Report incorrect company information